(Q34741437)

4 August 2017

1 reference

title

Hereditary angioedema: a current state-of-the-art review, VIII: current status of emerging therapies (English)

1 reference

4 August 2017

main subject

hereditary angioedema

1 reference

Jonathan A Bernstein

1

1 reference

4 August 2017

publication date

1 January 2008

1 reference

Annals of Allergy, Asthma & Immunology

4 August 2017

published in

1 reference

4 August 2017

volume

100

1 reference

4 August 2017

issue

1 Suppl 2

1 reference

4 August 2017

page(s)

S41-6

1 reference

A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations.

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Mutation screening of the C1 inhibitor gene among Hungarian patients with hereditary angioedema.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

C1 inhibitor deficiency: consensus document

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert P) in hereditary angioedema: a review. jean.de.serres@aventis.com

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Episodes of severe dyspnea caused by snoring-induced recurrent edema of the soft palate in hereditary angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Clinical management of hereditary angio-oedema in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Hereditary angioedema: causes, manifestations and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Viral safety of C1-inhibitor NF.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Scrapie removal using Planova virus removal filters

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Recombinant human C1-inhibitor in the treatment of acute angioedema attacks.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

DX-88 and HAE: a developmental perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Established and new treatments for hereditary angioedema: An update.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Anaphylactic reaction and antibodies to DX-88 (kallikrein inhibitor) in a patient with hereditary angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Bradykinin and inflammatory pain

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Bradykinin-mediated angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Bradykinin and the pathophysiology of angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Mechanism of angioedema in first complement component inhibitor deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Inhibition of bradykinin-induced vasodilation in human forearm vasculature by icatibant, a potent B2-receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960585-6

7 January 2021

10.1016/S1081-1206(10)60585-6

Identifiers

DOI

1 reference

4 August 2017

1 reference